Clinical Trial Update: Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase II study evaluating irinotecan liposome as first-line treatment for metastatic colorectal cancer is currently recruiting, sponsored by West China Hospital…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Irinotecan liposome (liposomal irinotecan)

Snippet

Sponsor: West China Hospital | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: RECRUITING